TriSalus Life Sciences, Inc. (TLSI)

NASDAQ: TLSI · Real-Time Price · USD

5.11

+0.09 (1.79%)

At close: May 12, 2025, 4:00 PM

5.11

0.00 (0.00%)

After-hours: May 12, 2025, 4:00 PM EDT

Revenue by Product

Fiscal year is January - December.

Fiscal Year	FY 2023
Period Ending	Dec '23 Dec 31, 2023
Innovative Drug Delivery Technology and Immune-oncology Therapeutics	18.51M

Revenue by Geography

Fiscal year is January - December.

Fiscal Year	FY 2023
Period Ending	Dec '23 Dec 31, 2023
United States	18.51M